Drug
Campath 1H Atg
Campath 1H Atg: highest development phase Phase 3, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Campath-1H /ATG NCT00226512 | Phase 3 | Acute Myeloid Leukemia |
Latest
No recent events.
Follow Campath 1H Atg on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.